Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV ActivityAnita Mathias, Brian P. Kearney, Aakanksha Jain et al.|Clinical Pharmacology & Therapeutics|2009Cited by 208
Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infectionRichard Elion, David R. Warren, Brian P. Kearney et al.|AIDS|2011Cited by 92